End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.77 USD | -1.03% |
|
-11.37% | -31.72% |
06-03 | TriSalus Life Sciences, Inc. Highlights Clinical Data from Phase 1b Perio-02 Trial | CI |
05-30 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
Quotes 5-day view
End-of-day quote Nasdaq10/06/2024 | 11/06/2024 | 12/06/2024 | 13/06/2024 | 14/06/2024 | |
---|---|---|---|---|---|
Last | 6.16 $ | 5.96 $ | 6.03 $ | 5.83 $ | 5.77 $ |
Volume | 31 206 | 24 199 | 47 359 | 29 085 | 23 706 |
Change | -5.38% | -3.25% | +1.17% | -3.32% | -1.03% |
Opening | 6.62 | 6.06 | 5.95 | 6.16 | 5.83 |
High | 6.62 | 6.24 | 6.16 | 6.16 | 6.18 |
Low | 6.07 | 5.89 | 5.78 | 5.71 | 5.77 |
Performance
1 day | -1.03% | ||
1 week | -11.37% | ||
Current month | -19.41% | ||
1 month | -40.52% | ||
3 months | -40.70% | ||
6 months | -31.72% | ||
Current year | -31.72% | ||
1 year | -45.00% | ||
3 years | -41.24% |
Volumes
marketsBasic data
Highs and lows
![Extreme 5.71](/images/extremecours_fleche.png)
![Extreme 5.71](/images/extremecours_fleche.png)
![Extreme 5.71](/images/extremecours_fleche.png)
![Extreme 3.32](/images/extremecours_fleche.png)
![Extreme 3.32](/images/extremecours_fleche.png)
![Extreme 3.32](/images/extremecours_fleche.png)
![Extreme 3.32](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-1.03% | -11.37% | -31.72% | -45.00% | 157M | ||
+0.35% | -0.48% | +18.15% | +38.18% | 124B | ||
+0.97% | +3.35% | +18.02% | +32.37% | 112B | ||
-0.58% | +2.34% | +4.45% | -0.36% | 22.94B | ||
-4.08% | -8.23% | -12.75% | -18.19% | 22.22B | ||
-2.28% | +3.98% | -9.86% | -18.80% | 17.02B | ||
-1.20% | -6.01% | -16.15% | -31.60% | 16.88B | ||
-2.89% | +3.09% | -39.94% | -39.14% | 16.87B | ||
-0.59% | +0.36% | +2.80% | +38.78% | 13.63B | ||
-1.73% | -0.39% | +27.39% | -5.83% | 11.61B | ||
+3.72% | +12.44% | +106.26% | +219.60% | 10.31B | ||
-1.45% | +2.78% | +16.15% | +42.60% | 7.94B | ||
-2.79% | -6.85% | -29.45% | -39.42% | 7.74B | ||
-0.13% | +3.79% | -2.04% | +22.13% | 7.57B | ||
-0.16% | -6.95% | +1.34% | +38.21% | 7.32B | ||
-1.00% | -0.64% | -9.38% | +13.88% | 6.33B | ||
Average | -0.93% | -0.21% | +2.70% | +15.46% | ||
Weighted average by Cap. | -0.23% | +0.69% | +10.51% | +24.02% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -31.72% | ||
2023 | -15.75% | ||
2022 | +1.52% | ||
2021 | -6.08% |
- Stock Market
- Equities
- TLSI Stock
- Quotes TriSalus Life Sciences, Inc.